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Abstract
Exercise hyperemia is regulated by several factors and one factor known to increase with exercise
that evokes powerful vasomotor action is extracellular ATP. The origination of ATP detectable in
plasma from exercising muscle of humans is, however, a matter of debate and ATP has been
suggested to arise from sympathetic nerves, blood sources (e.g. erythrocytes), endothelial cells,
and skeletal myocytes, among others. Therefore, we tested the hypothesis that acute augmentation
of sympathetic nervous system activity (SNA) results in elevated plasma ATP draining skeletal
muscle, and that SNA superimposition during exercise further increases ATP vs exercise alone.
We show that increased SNA via −40mmHg lower body negative pressure (LBNP) at rest does not
increase plasma ATP (51±8 vs 58±7 nmol/L with LBNP), nor does it increase [ATP] above levels
observed during rhythmic handgrip exercise (79±11 exercise alone vs 71±8 nmol/L with LBNP).
Secondly, we tested the hypothesis that active perfusion of skeletal muscle is essential to observe
increased plasma ATP during exercise. We identify that complete obstruction of blood flow to
contracting muscle abolishes exercise-mediated increases in plasma ATP (90±19 to 49±12 nmol/
L), and further, that cessation of blood flow prior to exercise completely inhibits the typical rise in
ATP (3 vs 61%; obstructed vs intact perfusion). The lack of ATP change during occlusion
occurred in the face of continued muscle work and elevated SNA, indicating the rise of
intravascular ATP is not resultant from these extravascular sources. Our collective observations
indicate that the elevation in extracellular ATP observed in blood during exercise is unlikely to
originate from sympathetic nerves or the contacting muscle itself, but rather is dependent on intact
skeletal muscle perfusion. We conclude that an intravascular source for ATP is essential and
points toward an important role for blood sources (e.g. red blood cells) in augmenting and
maintaining elevated plasma ATP during exercise.
Keywords
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Introduction
The control of blood flow and oxygen delivery to skeletal muscle during exercise is dynamic
and highly integrative in nature. Muscle contractions produce an assortment of vasomotor
responses resultant from the compressive mechanical forces of muscle contraction, local
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production of metabolic factors, and autonomic nervous system activation (Saltin et al.,
1998; Clifford & Hellsten, 2004). A common means by which exercise-induced stimuli can
signal a change in flow is through release of and subsequent communication via a signaling
molecule. One such molecule implicated in governing blood vessel diameter within active
muscle is extracellular ATP. Importantly, extracellular ATP is prevalent in venous plasma
draining skeletal muscle from humans and concentrations are known to rise significantly
during exercise (Forrester, 1972; Gonzalez-Alonso et al., 2002; Kirby et al., 2012). While
recent advances have shed substantial light on the unique vasomotor action of ATP (Kirby et
al., 2008; Rosenmeier et al., 2008; Crecelius et al., 2012) and identified the notable presence
of this transmitter in the luminal compartment (Gonzalez-Alonso et al., 2002; Mortensen et
al., 2011; Kirby et al., 2012), investigations have been limited with regard to characterizing
where blood extracellular ATP may originate from during exercise in humans.
A multitude of cell sources could prove to be the origin for intravascular ATP, though with
respect to conditions associated with contracting skeletal muscle, a few candidates are
likely. Evidence indicates that ATP is released from: (i) sympathetic nerve endings
following activation (Burnstock & Kennedy, 1986; Todorov et al., 1996), (ii) endothelial
cells and red blood cells during conditions of low oxygen and mechanical stress (Yang et al.,
1994; Bodin & Burnstock, 1995; Ellsworth et al., 1995; Sprague et al., 1998), and (iii)
skeletal myocytes during contraction (Hellsten et al., 1998; Buvinic et al., 2009; Mortensen
et al., 2009). Whether any of these candidates give rise to elevated plasma ATP during
exercise in humans is unclear.
The overall aim of the present study was to gain insight into which cell source(s) might act
as the site of origination for increased extracellular ATP during moderate intensity exercise
in humans. Accordingly, we tested the hypothesis that: (a) sympathetic nervous system
activation results in nerve ending release of ATP that is detectable in the intravascular space,
and (b) blood flow (i.e. muscle perfusion) during exercise is critical to the elevation in
plasma ATP during exercise, suggesting release from an intravascular source such as blood
and/or endothelial cells. To do so, we employed a lower body negative pressure system to
elicit sympathetic nervous system activation alone and during exercise, and blood flow-
occlusion methodology to inhibit erythrocyte delivery and minimize stimulus-induced
release from erythrocytes and endothelial cells in the face of continued muscle contractions.
Methods
Subjects
With Institutional Review Board approval and after written informed consent, a total of 18
young healthy adults (16 men, 2 women; age = 24± 1 years; weight = 73± 1.3 kg; height =
176 ± 1 cm; body mass index = 23.6± 0.5 kg/m2; % body fat = 21.7%; and MVC of 47 ± 2
kg; means±S.E.M) participated in the present study. All were non-smokers, non-obese,
normotensive, and not taking any medications. Studies were performed after a 4-hour fast
with the subjects in the supine position. All studies were performed according to the
Declaration of Helsinki.
Arterial Blood Pressure and Heart Rate
Resting arterial blood pressure was measured in duplicate non-invasively over the brachial
artery of the control arm after 15 minutes of supine rest before experimental trials
(Cardiocap/5, Datex-Ohmeda, Louisville, CO, USA). Beat-by-beat arterial blood pressure
(MAP) was measured at heart level by finger photoplethysmography (Finometer, FMS,
Netherlands) on the middle finger of the control hand during each trial. Heart rate was
determined using a 3-lead ECG (Cardiocap/5, Datex-Ohmeda, Louisville, CO, USA).
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Forearm Blood Flow and Vascular Conductance
A 12 MHz linear-array ultrasound probe (Vivid 7, General Electric, Milwaukee, WI, USA)
was used to measure brachial artery mean blood velocity (MBV) and brachial artery
diameter and was placed in a holder securely fixed to the skin proximal to the catheter site as
previously described by our laboratory (Kirby et al., 2012). For blood velocity
measurements, the probe insonation angle was maintained at <60° and the frequency used
was 5 MHz. The Doppler shift frequency spectrum was analyzed via a Multigon 500M TCD
(Multigon Industries, Mt. Vernon, NY) spectral analyzer from which mean velocity was
determined as a weighted mean of the spectrum of Doppler shift frequencies. Brachial artery
diameter measurements were made in triplicate in duplex mode at end diastole and between
contractions during steady-state conditions. Forearm blood flow (FBF) was calculated as:
FBF = MBV (cm/s) * π (brachial artery diameter/2)2 * 60, where the FBF is in ml/min, the
MBV is in cm/s, the brachial diameter is in cm, and 60 is used to convert from ml/s to ml/
min. As an index of forearm vascular tone (and vasodilation), forearm vascular conductance
(FVC) was calculated as (FBF/MAP) * 100, and expressed as ml/min /100 mmHg. Studies
were performed in a cool temperature-controlled environment with a fan directed toward the
forearm to minimize the contribution of skin blood flow to forearm hemodynamics.
Rhythmic Handgrip Exercise
Maximum voluntary contraction (MVC) was determined for each subject as the average of
at least three maximal squeezes of a handgripdynamometer (Stoelting, Chicago, IL, USA)
that were within 3 percent of each other. For the exercise trials, weights corresponding to
15% MVC were attached to a pulley system and lifted 4–5 cm over the pulley at a duty
cycle of 1 s contraction-2 s relaxation (20 contractions per minute) using audio and visual
signals to ensure the correct timing. We have recently demonstrated that handgrip exercise
at this intensity increases venous plasma ATP draining the contracting tissue (Kirby et al.,
2012).
Sympathetic Nervous System Activation via Lower Body Negative Pressure
Subjects lay supine and weresealed at the level of the iliac crests in a chamber designed for
administering lower body negative pressure (LBNP) (Kirby et al., 2005). LBNP was
administered at −40 mmHg to unload cardiopulmonary and arterial baroreceptors and evoke
reflex increases in muscle sympathetic nerve activity (Davy et al., 1998). This level of
LBNP was administered for 2 minutes and was chosen because it evokes reproducible
increases in sympathetic vasoconstrictor activity. Previous studies in our laboratory indicate
that, when separated by 15 minutes of rest, the forearm vasoconstrictor response to LBNP
under resting conditions are repeatable over time (Kirby et al., 2005).
Blood Flow Occlusion via Cuff Inflation
Blood flow was occluded by rapidly inflating a blood pressure cuff to suprasystolic blood
pressure (≥ 200mmHg ; D.E. Hokanson, Bellevue, WA, USA). The cuff was placed around
the upper arm proximal to the ultrasound probe. Obstruction was confirmed by identification
of a complete loss in the blood velocity signal.
Venous Catheterization
A choice of 18 – 22 gauge 5.1 cm catheter, depending on visual assessment of vein size, was
inserted at the antecubital crease in retrograde fashion into a vein draining the muscle tissue
of the experimental arm for venous blood samples to be used for ATP determination and
blood gas analysis via clinical blood gas analyzer (Siemens Rapid Point 405 Series
Automatic Blood Gas System, Los Angeles, CA). Saline was continuously infused through
this catheter at a rate of approximately 3 ml/minfor the duration of the study to keep it patent
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(Kirby et al., 2012). In the present investigation we focused on venous ATP given that (a)
we previously demonstrated that graded rhythmic handgrip exercise does not significantly
elevate arterial [ATP] and (b) ATP in the arterial circulation is undetectable in venous
samples given the rapid (< 1 sec) breakdown by nucleotidases (Pearson et al., 1980;
Mortensen et al., 2011; Kirby et al., 2012).
Sampling and Measurement of Plasma ATP
Blood was drawn by syringe, immediately centrifuged, and plasma assayed for ATP as
previously described in detail (Kirby et al., 2012). Venous blood was sampled and used for
ATP measurement because this blood is post exposure to the microcirculation, and during
forearm exercise arterial ATP sampled from the brachial artery changes minimally (Kirby et
al., 2012). Briefly, venous blood was drawn through the catheter directly into a pre-
heparinized 10cc syringe in which 2 ml of blood was at once gently expelled into a tube
containing 2.7 mL of an ATP stabilizing solution to equal a blood:diluent ratio of 1.35
(Gorman et al., 2007; Kirby et al., 2012). The ATP stabilizing solution was used to inhibit
degradation of ATP via nucleotidases and additional ATP release post sampling.
Blood:diluent samples were immediately centrifuged at 4,000 rpm for 3 minutes at 22°C.
Directly following centrifugation, 100 μL of supernatant was taken for plasma ATP
determination via luciferin-luciferase assay. An ATP standard curve was created on the day
of the experiment prior to all experimental trials and in plasma medium from each subject
studied.
Because small amounts of RBC hemolysis can lead to significant increases in ATP, samples
were accounted for with a hemolysis-ATP calculation (Kirby et al., 2012). 1 mL of
supernatant from the same blood:diluent sample used for plasma [ATP] measurements was
analyzed for plasma Hb via spectrophotometry (Molecular Devices SpectraMax) at
wavelengths 415, 380, and 450. This plasma [Hb] reading provided an indication of
hemolysis (% Hemolysis = {(100 − HCT) * p[Hb]/t[Hb]}*100). Any sample that was more
than 2 standard deviations from the mean in % hemolysis was excluded in the analysis and
considered technical error.
Experimental Protocols
Protocol 1: Influence of Sympathetic Nervous System Activation on Venous Plasma ATP
The purpose of this protocol was to determine whether sympathetic activation results in
significantly elevated plasma ATP or further augments plasma ATP during exercise. While
in the supine position, subjects (N = 9) underwent both of the following trials in a
randomized order with trials separated by at least 30 minutes. One trial consisted of 2
minutes of quiet rest followed by 2 minutes of −40 mmHg LBNP, where this level of LBNP
elicits robust sympathetic nervous system activation (Davy et al., 1998). The other trial
involved 2 minutes of quiet rest followed by 6 minutes of continuous rhythmic dynamic
handgrip exercise performed at a moderate intensity (15% MVC). LBNP at −40 mmHg was
superimposed during forearm exercise for the final 2 minutes of this trial. Blood samples
were collected at the end of rest, exercise, or LBNP.
Protocol 2: Influence of Obstructing Skeletal Muscle Perfusion During Moderate Intensity
Exercise on Venous Plasma ATP
The purpose of this protocol was to determine whether obstructing skeletal muscle perfusion
as a means to inhibit erythrocyte delivery and minimize stimulus-induced release of ATP
from erythrocytes and endothelial cells during exercise results in reduced plasma ATP or an
inability to elevate plasma during exercise. To do so, subjects were instrumented with a
blood pressure cuff wrapped around the upper arm proximal to the anitecubital fossa that
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was connected to a rapid cuff inflation unit (Hokanson, Bellevue, WA, USA). A total of 3
trials were performed in a randomized order. Two minutes of quiet rest took place prior to
each trial. One trial (N = 9) consisted of 6 minutes of continuous moderate intensity
handgrip exercise and thus acted as a time control trial to characterize the expected change
in plasma ATP during unobstructed flow conditions. A second trial (N = 9) was conducted
to determine whether muscle perfusion was necessary to maintain high levels of plasma
ATP, and was performed similar to the time control trial, yet the last two minutes of exercise
were performed in conjunction with complete obstruction of blood flow to the forearm
achieved via inflation of the blood pressure cuff to suprasystolic levels (200 mmHg). A third
trial (N = 8) was conducted to determine the capacity to increase plasma ATP during
moderate exercise when tissue perfusion is obstructed prior to onset of exercise. This trial
involved 2 minutes of rest with perfusion followed by two minutes of rest with complete
occlusion via blood pressure cuff inflation. Moderate intensity handgrip exercise was then
initiated for 2 minutes while occlusion was maintained. All subjects rested for a minimum of
30 minutes between each trial. Blood samples were collected at the end of rest, exercise, or
occlusion + exercise.
Data Acquisition and Analysis
Data was collected and stored on computer at 250 Hz and analyzed off-line with signal-
processing software (WinDaq, DATAQ Instruments, Akron, OH, USA). Mean arterial
pressure (MAP) was determined from the arterial pressure waveform. An average of 30
seconds was calculated for FBF, FVC, HR, and MAP for each trial segment of interest.
Sigmaplot (Systat Software) was used for all statistical comparisons.
Statistics
All values are reported as means ± S.E.M. Specific hypothesis testing within each trial was
performed using a one-way repeated measures ANOVA, and for the case of a significant F,
Student Newman Kuels post hoc analysis was performed. Comparison of ATP values at
specific time points were made with unpaired t-tests, and the values within a condition with
paired t-tests. Significance was set a priori at P<0.05.
Results
Protocol 1: Influence of Sympathetic Nervous System Activation on Venous Plasma ATP
Forearm and systemic hemodynamics for Protocol 1 are presented in Table 1 and blood gas
parameters are presented in Table 2. LBNP evoked significant reductions in forearm blood
flow at rest (−31 ± 4%; P<0.05) confirming efficacy of the LBNP system to activate the
sympathetic nervous system and evoke vasoconstriction. Despite substantial sympathetic
nervous system activation, venous plasma ATP was not greater with addition of LBNP
(51±8 vs 58±7 nmol/L; Figure 1A). In the exercise trial, moderate intensity handgrip
exercise elicited significant increases in ATP (P<0.05) but these values were unaltered by
SNA superimposition (47±5, 79±11, and 71±8 nmol/L; Rest, Exercise, and Exercise +
LBNP; respectively; Figure 1B). As expected, functional sympatholysis occurred during
exercise and thus limited our ability to detect vasoconstriction as an index of SNA (Kirby et
al., 2005). Nevertheless, augmentation of SNA was evidenced by a significant increase in
heart rate resultant from LBNP (Table 1).
Protocol 2: Influence of Obstructing Skeletal Muscle Perfusion during Moderate Intensity
Exercise on Venous Plasma ATP
Forearm and systemic hemodynamics for Protocol 2 are presented in Table 3 and blood gas
parameters are presented in Table 4. Forearm handgrip exercise (15% MVC) elicited a
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significant elevation in plasma ATP in both the time control trial (53±5 vs 75±11 nmol/L;
Figure 2A) and the occlusion trial prior to blood flow obstruction (50±7 vs 90±20 nmol/L;
Figure 2B), resulting in an average increase of ~60% from resting baseline. However during
the occlusion, plasma ATP was significantly reduced from steady state exercise levels
(Figure 3), and was no longer greater than rest (49±12 nmol/L; Figure 2B). In contrast,
plasma ATP during continued exercise with freely perfused conditions was unaltered (Δ
3±9%; Figure 3) and maintained above rest (72±8 nmol/L; Figure 2A). In the trial where
occlusion occurred at rest prior to exercise, a small but non-significant increase in ATP was
observed following cuff inflation at rest (63±5 vs 72±11 nmol/L; P=0.49; Figure 2C),
however exercise was unable to significantly augment plasma ATP concentrations (Δ
3±17%) compared to that seen with flow-unobstructed exercise (Δ 61±13%; Figure 4).
As a result of exercise combined with blood flow obstruction, a significant elevation in
mean arterial pressure was observed in both trials utilizing this approach (‘Exercise then
occlusion’ and ‘Occlusion then Exercise’; Table 3). This observation is consistent with
muscle metaboreflex activation often observed when oxygen demand exceeds oxygen
delivery (O’Leary et al., 1999), and provides an indication that substantial sympathetic
activation had occurred (Fadel et al., 2003). Lastly, all subjects were able to continue
handgrip exercise despite blood flow obstruction indicating that muscle work performed was
maintained throughout trials. Confirming this, blood gas analysis data are provided in Table
4 and depict the directional changes in parameters expected from increased metabolic
activity alone and in combination with reduced oxygen delivery (i.e. ischemia).
Discussion
The present investigation was designed to gain insight into which cell sources contribute to
the increase in plasma ATP draining active skeletal muscle during exercise in humans. We
demonstrate that sympathetic activation via LBNP does not increase venous plasma ATP
draining skeletal muscle at rest nor during moderate intensity forearm exercise, indicating a
limited contribution of ATP from sympathetic nerves to intravascular ATP concentrations
during exercise. Next, we identify that skeletal muscle perfusion is obligatory to maintain
increased levels of intravascular ATP during exercise despite augmentation of ATP
releasing stimuli (e.g. hypoxemia), and that plasma ATP cannot increase during exercise
without intact muscle perfusion. This phenomenon occurs in spite of continued muscle
contractions and endogenous reflex activation of the sympathetic nervous system, arguing
against the muscle itself and confirming that sympathetic nerves are unlikely to be
significant sources for extracellular ATP found within blood. We conclude that
augmentation and maintenance of elevated intravascular ATP during exercise requires intact
skeletal muscle perfusion and suggests an important role for blood and/or endothelial cells
as an intravascular ATP source.
Sympathetic Nerves as a Source for Plasma ATP in Humans
While norepinephrine-mediated vasoconstriction clearly results from sympathetic activation,
ATP can also be co-released from sympathetic nerves and lead to vasoconstriction
(Burnstock & Kennedy, 1986; Todorov et al., 1996; Kluess et al., 2010). Additionally,
stimulation of purinergic 2X receptors appears to provide a tonic vasoconstrictor signal
during exercise in which the sympathetic nervous system is activated (Buckwalter et al.,
2004), further substantiating such claims of nerve-mediated ATP release and associated
vasoconstriction. In humans, ATP increases in the interstitial space during exercise and may
in part result from elevated sympathetic activity (Li et al., 2005; Cui et al., 2011). While a
recent study aimed to address a similar question to ours through intra-arterial administration
of tyramine (to evoke endogenous spillover of norepinephrine) (Mortensen et al., 2011),
tyramine does not authentically elevate sympathetic nerve activity and fails to evoke co-
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release of neuronal ATP (Muramatsu, 1987; Driessen et al., 1996). Rather, usage of LBNP
in humans does appear to elicit nerve-mediated ATP release (Pelleg & Burnstock, 1990;
Taddei et al., 1990), and was therefore used as our stimulus to increase sympathetic nervous
system activation. We hypothesized that intravascular ATP may result as overflow from
nerve release of ATP in humans.
In contrast to our hypothesis, extracellular ATP was not increased in the blood draining
skeletal muscle as a result of sympathetic activation despite significant elevations in
sympathetic outflow (Figure 1A). Further, while moderate intensity forearm exercise
stimulated a significant rise in plasma ATP, this was not augmented following addition of
LBNP during this high flow condition (Figure 1B). Consistent with this logic, handgrip
exercise of mild-to-moderate intensity does not significantly increase SNA (Victor & Seals,
1989; Seals & Victor, 1991), yet plasma ATP is increased during exercise at these
workloads (present study and (Kirby et al., 2012). Collectively, these data suggest that
sympathetic nerves are unlikely to be a principal source for extracellular ATP within the
blood of humans during exercise.
Impact of Exercise and Altered Skeletal Muscle Perfusion on Venous Plasma ATP in
Humans
While exercise hyperemia, and the milieu created by muscle contractions are associated with
a rise in plasma ATP in vivo, what specifically about exercise is cause for elevated
intravascular ATP is unclear. Nevertheless, important roles for hemoglobin conformational
state (Gonzalez-Alonso et al., 2002; Farias et al., 2005; Akatsu et al., 2010; Kirby et al.,
2012) and the modulation by acidosis (Ellsworth et al., 1995), hypercapnia (Bergfeld &
Forrester, 1992), or temperature (Kalsi & Gonzalez-Alonso, 2012), as well as tissue
mechanical compression (Crecelius et al., 2010; Mortensen et al., 2011) have all been put
forth as potential mediators for increased plasma ATP in various models. All of these stimuli
occur with muscle contractions. One obvious aspect of these exercise-mediated stimuli
associated with elevated intravascular ATP is the substantial overlap with basic erythrocyte
function, and interestingly, erythrocytes are well recognized to release ATP in response to
all of the above stated stimuli (Ellsworth et al., 2009). Additionally, endothelial cells may
also release ATP in response to low oxygen and increased mechanical stress (Bodin et al.,
1991; Bodin & Burnstock, 1995). The latter however has been refuted as a means to increase
ATP because pharmacologically-induced increases in blood flow (and concurrent shear
stress) do not elevate plasma ATP in humans (Mortensen et al., 2009; Kirby et al., 2012).
Our goal in protocol 2 was to cause complete occlusion of blood flow to the active muscle as
a means to: (a) inhibit red blood cell delivery to the stimulus rich environment, and (b)
significantly reduce the stimulus-induced release from red cells and/or endothelial cells (e.g.
shear stress) to release ATP. Because these intravascular cell sources are associated with
ATP release to stimuli known to increase plasma ATP, we hypothesized that elevations in
plasma ATP during exercise are dependent on intact muscle perfusion.
The results of Protocol 2 clearly demonstrate that inhibition of blood flow to active skeletal
muscle after initiation of exercise abolishes the normal rise in plasma ATP, such that ATP is
returned to resting baseline levels (Figure 2B). Moreover, this reduction in ATP seen during
complete occlusion clearly contrasts the lack of change in plasma ATP observed when
muscle perfusion remains uninterrupted (Figure 3). These observations occur in the face of
augmented stimuli for ATP release during occlusion (e.g. hypoxemia) and highlight the
crucial contribution of muscle perfusion in detecting elevated intravascular ATP. When we
reversed the experimental design and fully obstructed muscle blood flow prior to exercise,
elevations in intravascular ATP during muscle contractions were completely inhibited (< 5%
increase vs ~60% with perfusion intact; Figure 4). It is important to note that these subjects
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in Protocol 2 were able to continue forearm contractions without faltering during full
occlusion, indicating muscle work was unchanged. Thus, if ATP release were occurring
from muscle and interstitial ATP were passing into blood, then a maintained elevation in
plasma ATP would have been expected, but this did not occur. Taken together, our findings
demonstrate an obligatory role for skeletal muscle perfusion in mediating the rise in plasma
ATP with exercise and are consistent with the concept that extracellular ATP within the
bloodstream originates from an intravascular source rather than from the extravascular
compartment.
Lastly, a noticeable rise in mean arterial blood pressure was observed during ischemic
exercise resultant from metaboreflex activation indicating clear sympathetic nervous system
engagement (Victor et al., 1987). Yet, plasma ATP was still diminished during occlusion
and unable to rise significantly when exercise was initiated (Figure 3 & 4). This observation
serves to substantiate our primary findings from Protocol 1. Our collective observations
indicate that sympathetic nerves and skeletal muscle that may contribute to extravascular
ATP are unlikely to be the dominant sites for exercise-mediated elevations in intravascular
ATP of humans. Rather, it is more apparent that something specific to the delivery of blood
is obligatory to augment plasma ATP concentrations during moderate intensity exercise;
presumably the continuous presence of new red blood cells.
How Might Perfusion Be Crucial to Elevated Intravascular ATP?
Observations from human studies suggest that enhanced shear stress is unlikely the cause for
increased ATP from exercise (Mortensen et al., 2009; Kirby et al., 2012), and may indicate a
relatively weak role for endothelial cell derivation as the principal plasma ATP source. The
present study completely inhibited the replenishment of fresh erythrocytes to the stimuli rich
environment. In this manner, ATP in plasma resultant from red cells is likely to be
substantially reduced without addition of fresh red cells because no new cells are delivered
and ATP release from already present cells does not largely increase as a result of increased
exposure time to a stimulus (Sprague et al., 2009; Kalsi & Gonzalez-Alonso, 2012).
Therefore, it is presumable that increases in erythrocyte delivery and the renewal of fresh
red cells to active muscle are of utmost importance in augmenting plasma ATP during
exercise.
Along these lines, another point of thought relates to the detailed interaction between
exercise intensity and the associated magnitude of hyperemia and ATP releasing stimuli. We
notice in protocol 1, LBNP evoked ~30% reduction in blood flow and a concurrent rise in
stimuli for ATP release (e.g. deoxygenation), but plasma ATP was not significantly altered
(up nor down). Observations such as these may suggest an acute regulatory balance between
blood flow and ATP releasing stimuli that works in unison to optimize ATP release and its
impact on vessel tone, rather than an all-or-none phenomenon. Hence, our current working
hypothesis is that factors associated with muscle contraction not only create stimulus for
immediate ATP release but may also in effect facilitate the augmentation of blood flow and
additional red cell delivery for sustained balance. This interaction between exercise
hyperemia and stimulus may also be modulated by ectoenzymes to provide the net plasma
ATP concentrations, thus controlling the transmitter for purinergic receptor activation and
the ensuing vasomotor response. A detailed schematic of this working hypothesis is
presented as Figure 5.
Experimental Considerations
Occlusion completely abrogated exercise hyperemia yet ATP was still detected in the
plasma suggesting release from certain sources occurs to some extent independent of active
perfusion. Whether this is associated with reductions in ectoenzyme activity (from loss of
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blood flow/shear stress (Yegutkin et al., 2000)) or a general basal ATP release from an
unidentified source is indiscernible, but further study is warranted. Alternatively, because
we completely occluded arterial inflow and venous outflow by way of a blood pressure cuff,
blood within the ‘enclosed’ space was effectively stagnant and thus endogenous ATP
concentrations could also have been impacted by local ectoenzymes and/or the ADP
suppression effect on red cell ATP release (Pearson et al., 1980; Wang et al., 2005).
Regardless, our data clearly demonstrate a crucial need for continuous intact skeletal muscle
perfusion in order to elevate and effectively maintain high levels of extracellular ATP within
the vessel lumen during exercise in humans.
A separate consideration is that if ATP were able to bypass the endothelium from muscle to
plasma, muscle ATP release could have been reduced during ischemia by way of limiting
oxygen delivery as a substrate for ‘aerobic’ metabolism. This is unlikely to explain our
observations because muscle glycogen stores are plentiful and do not deplete within minutes
and are sufficient to sustain ATP production (Bertocci et al., 1992). Further, low oxygen
may evoke, if anything, an increase in ATP release from muscle rather than a decrease
(Clemens & Forrester, 1981).
Conclusions
The results from the present investigation demonstrate that sympathetic nervous system
activation does not result in elevated intravascular ATP at rest nor augments exercise-
mediated increases in plasma ATP. Alternatively, elevations in plasma ATP as a result of
moderate intensity exercise were abolished by completely limiting perfusion to the active
skeletal muscle and ATP did not elevate when blood flow was impeded prior to the onset of
exercise, despite increased stimuli for release. Given that muscle contractions persisted in
the face of blood flow occlusion and plasma ATP was unaffected, it can be concluded that
extracellular ATP is unlikely to originate from the active muscle itself. Taken together, our
observations suggest increased delivery of blood to the working muscle resultant from
exercise is requisite for exercise-induced augmentation and maintenance of intravascular
ATP in humans.
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New Findings
• What is the central question of this study?
• Plasma ATP increases during exercise in humans, but whether ATP
predominantly originates from extravascular (nerves and muscle) or
intravascular (blood and endothelial cells) sources is unclear.
• What is the main finding and its importance?
• The collective observations indicate that neither sympathetic nerves nor active
skeletal muscle are likely to be origin for intravascular ATP during dynamic
muscle contractions in humans. Further, elevations in skeletal muscle perfusion
are requisite to increase and maintain high plasma ATP during exercise,
suggesting ATP release from an intravascular cell source.
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Figure 1. A–B: Protocol 1 – Impact of Sympathetic Nervous System Activation on Venous
Plasma ATP at Rest and During Exercise
Lower body negative pressure (LBNP) at −40 mmHg was utilized to augment sympathetic
nervous system activity (SNA). SNA had no independent effect on venous plasma ATP
when superimposed at rest (A) or during moderate intensity foreram handgrip exercise (B).
* P <0.05 vs rest alone.
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Figure 2. A–C: Protocol 2 – Impact of Occluding Skeletal Muscle Blood Flow during Exercise on
Venous Plasma ATP
Moderate intensity forearm handgrip exercise evoked significant elevations in venous
plasma ATP during both steady state (SS; 4 minutes) and at end exercise (6 minutes) time
points (A). When skeletal muscle perfusion ceased via complete blood flow occlusion
(Occl), plasma ATP was significantly reduced from SS exercise and was no longer greater
than rest (B). Application of a cuff to completely occlude forearm blood flow prior to
exercise abolished any significant increase in plasma ATP resultant from exercise (C). * P
<0.05 vs rest; † P <0.05 vs SS Ex.
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Figure 3. Protocol 2 – Effects of Obstructing Skeletal Muscle Blood Flow During Forearm
Exercise on Steady-State Plasma ATP
During forearm exercise, steady-state plasma ATP concentrations are unaffected when
muscle perfusion is uninterrupted (intact condition). In contrast, a significant reduction in
plasma ATP is observed during blood flow occlusion. * P <0.05 vs intact perfusion.
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Figure 4. Protocol 2 – Change in Venous Plasma ATP from Rest to Exercise with Intact and
Occluded Skeletal Muscle Blood Flow
Moderate intensity forearm exercise evokes a significant increase in venous plasma ATP
that is not observed when skeletal muscle perfusion is completely obstructed prior to
initiation of muscle contractions. * P <0.05 vs intact perfusion; † P <0.05 vs zero.
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Figure 5. Schematic Depicting Potential Sources of Intravascular ATP
ATP may be released from skeletal muscle and sympathetic nerves to accumulate in the
interstitial space during muscle contractions (i.e. extravascular ATP), however this ATP is
unlikely to bypass the vascular wall due to endothelial ectonucleotidases. ATP is also
released from intravascular cell sources, erythrocytes and endothelial cells in response to
specific stimuli concurrent with muscle contractions. Both blood flow/red blood cell
delivery and ATP releasing stimuli act in tandem with ATP consuming processes to regulate
the absolute plasma ATP concentration (i.e. intravascular ATP). ATP can elicit
vasoconstriction, vasodilation, or blunt sympathetic vasoconstriction depending on the
location/subtype of purinergic receptor activation. P, Purinergic receptor; ATP, adenosine
triphosphate; ADO, adenosine; RBC, red blood cell; NE, norepinephrine.
Kirby et al. Page 18
Exp Physiol. Author manuscript; available in PMC 2014 May 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Kirby et al. Page 19
Ta
bl
e 
1
Fo
re
ar
m
 a
nd
 S
ys
te
m
ic
 H
em
od
yn
am
ic
s i
n 
Pr
ot
oc
ol
 1
Tr
ia
l
C
on
di
tio
n
Fo
re
ar
m
 B
lo
od
 F
lo
w
 (m
l/m
in)
M
ea
n 
A
rt
er
ia
l P
re
ss
ur
e 
(m
mH
g)
Fo
re
ar
m
 V
as
cu
la
r 
C
on
du
ct
an
ce
 (m
l/m
in/
10
0 m
mH
g)
H
ea
rt
 R
at
e 
(b
ea
ts/
mi
n)
LB
N
P 
du
ri
ng
 R
es
t
R
es
t
27
.5
±2
.9
93
±2
29
.9
±3
.2
56
±3
+
LB
N
P
18
.8
±2
.0
*
92
±3
20
.5
±2
.1
*
63
±2
*
LB
N
P 
du
ri
ng
 E
xe
rc
ise
R
es
t
27
.1
±2
.1
93
±3
29
.5
±2
.8
57
±3
15
%
 E
x
20
6.
8±
12
.5
*
97
±3
21
4.
4±
15
.2
*
63
±3
*
+
LB
N
P
19
9.
5±
13
.7
*
97
±3
20
6.
4±
14
.8
*
71
±2
*
†
*
P<
0.
05
 v
s 
R
es
t;
† P
<
0.
05
 v
s 
15
%
 E
x
Exp Physiol. Author manuscript; available in PMC 2014 May 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Kirby et al. Page 20
Ta
bl
e 
2
V
en
ou
s B
lo
od
 G
as
es
 in
 P
ro
to
co
l 1
Tr
ia
l
C
on
di
tio
n
pH
pO
2 
(m
mH
g)
pC
O
2 
(m
mH
g)
FO
2H
b 
(%
)
LB
N
P 
at
 R
es
t
R
es
t
7.
36
±0
.0
1
29
.8
±2
.0
48
.8
±1
.9
50
.5
±3
.9
+
LB
N
P
7.
35
±0
.0
1
25
.3
±1
.3
*
49
.2
±1
.9
41
.0
±3
.3
*
LB
N
P 
du
ri
ng
 E
xe
rc
ise
R
es
t
7.
35
±0
.0
1
28
.2
±2
.1
49
.9
±1
.8
46
.8
±4
.9
15
%
 E
x
7.
30
±0
.0
1*
22
.7
±0
.5
*
60
.0
±1
.5
*
31
.3
±1
.3
*
+
 L
BN
P
7.
30
±0
.0
1*
19
.4
±0
.6
*
†
61
.1
±2
.6
*
24
.8
±1
.3
*
†
*
P 
<
 0
.0
5 
v
s 
R
es
t;
† P
 
<
 0
.0
5 
v
s 
15
%
 E
x
Exp Physiol. Author manuscript; available in PMC 2014 May 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Kirby et al. Page 21
Ta
bl
e 
3
Fo
re
ar
m
 a
nd
 S
ys
te
m
ic
 H
em
od
yn
am
ic
s i
n 
Pr
ot
oc
ol
 2
Tr
ia
l
C
on
di
tio
n
Fo
re
ar
m
 B
lo
od
 F
lo
w
 (m
l/m
in)
M
ea
n 
A
rt
er
ia
l P
re
ss
ur
e 
(m
mH
g)
Fo
re
ar
m
 V
as
cu
la
r 
C
on
du
ct
an
ce
 (m
l/m
in/
10
0 
m
m
H
g)
H
ea
rt
 R
at
e 
(b
ea
ts/
mi
n)
Ti
m
e 
C
on
tr
ol
 E
xe
rc
ise
R
es
t
29
.3
±2
.9
87
±1
33
.7
±3
.1
51
±3
15
%
 E
x 
M
in
 4
22
2.
1±
22
.2
*
93
±2
*
23
7.
1±
22
.4
*
56
±3
*
15
%
 E
x 
M
in
 6
22
7.
7±
22
.8
*
94
±2
*
23
9.
1±
21
.3
*
56
±3
*
Ex
er
ci
se
 th
en
 O
cc
lu
sio
n
R
es
t
34
.7
±3
.0
86
±2
40
.4
±3
.5
54
±2
15
%
 E
x
22
8.
8±
12
.1
*
91
±2
*
25
0.
1±
11
.0
*
58
±2
15
%
 E
x 
+ 
O
cc
lu
sio
n
0.
0±
0.
0*
†
10
9±
3*
†
0.
0±
0.
0*
†
67
±4
*
†
O
cc
lu
sio
n 
th
en
 E
xe
rc
ise
R
es
t
30
.0
±3
.3
87
±2
34
.2
±3
.4
52
±3
O
cc
lu
sio
n
0.
0±
0.
0*
87
±1
0.
0±
0.
0*
54
±3
O
cc
lu
sio
n 
+ 
15
%
 E
x
0.
0±
0.
0*
10
2±
2*
†
0.
0±
0.
0*
61
±4
*
†
*
P 
<
 0
.0
5 
v
s 
R
es
t;
† P
 
<
 0
.0
5 
v
s 
pr
io
r t
im
ep
oi
nt
Exp Physiol. Author manuscript; available in PMC 2014 May 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Kirby et al. Page 22
Ta
bl
e 
4
V
en
ou
s B
lo
od
 G
as
es
 in
 P
ro
to
co
l 2
Tr
ia
l
C
on
di
tio
n
pH
pO
2 
(m
mH
g)
pC
O
2 
(m
mH
g)
FO
2H
b 
(%
)
Ti
m
e 
C
on
tr
ol
 E
xe
rc
ise
R
es
t
7.
36
±0
.0
1
30
.9
±2
.3
46
.0
±1
.4
54
.5
±4
.7
15
%
 E
x 
M
in
 4
7.
29
±0
.0
1*
22
.9
±0
.7
*
59
.1
±2
.1
*
32
.2
±1
.6
*
15
%
 E
x 
M
in
 6
7.
29
±0
.0
1*
22
.4
±0
.7
*
59
.0
±2
.0
*
31
.2
±1
.3
*
Ex
er
ci
se
 th
en
 O
cc
lu
sio
n
R
es
t
7.
37
±0
.0
1
26
.1
±1
.2
45
.0
±1
.6
45
.0
±3
.0
15
%
 E
x
7.
30
±0
.0
1*
22
.9
±0
.7
*
57
.0
±1
.7
*
32
.0
±1
.3
*
15
%
 E
x 
+ 
O
cc
lu
sio
n
7.
27
±0
.0
2*
18
.9
±1
.3
*
†
57
.5
±3
.6
*
22
.4
±2
.7
*
†
O
cc
lu
sio
n 
th
en
 E
xe
rc
ise
R
es
t
7.
36
±0
.0
1
28
.5
±2
.2
47
.4
±1
.6
48
.7
±5
.0
O
cc
lu
sio
n
7.
36
±0
.0
1
27
.4
±1
.0
41
.3
±2
.2
*
46
.0
±2
.8
O
cc
lu
sio
n+
 1
5%
 E
x
7.
35
±0
.0
1
24
.2
±0
.9
*
†
40
.6
±2
.3
*
37
.7
±1
.8
*
†
*
P 
<
 0
.0
5 
v
s 
R
es
t;
† P
 
<
 0
.0
5 
v
s 
pr
io
r t
im
ep
oi
nt
Exp Physiol. Author manuscript; available in PMC 2014 May 01.
